![]() | Up a level |
Malekzadeh, R. and Abedini, A. and Mohsenpour, B. and Sharifipour, E. and Ghasemian, R. and Javad-Mousavi, S.A. and Khodashahi, R. and Darban, M. and Kalantari, S. and Abdollahi, N. and Salehi, M.R. and Rezaei Hosseinabadi, A. and Khorvash, F. and Valizadeh, M. and Dastan, F. and Yousefian, S. and Hosseini, H. and Anjidani, N. and Tabarsi, P. (2020) Subcutaneous tocilizumab in adults with severe and critical COVID-19: A prospective open-label uncontrolled multicenter trial. International Immunopharmacology, 89.